DarioHealth Corp. (DRIO) |
15.3 -0.39 (-2.49%) 10-10 16:00 |
Open: | 15.65 |
High: | 15.65 |
Low: | 15.09 |
Volume: | 29,819 |
Market Cap: | 696(M) |
PE Ratio: | -1.14 |
Exchange: | NASDAQ Capital Market |
Industry: | Medical - Diagnostics & Research |
Sector: | Healthcare |
Technical analysis | ||||
![]() |
||||
sell | buy |
Resistance 2: | 20.72 |
Resistance 1: | 17.74 |
Pivot price: | 14.38 |
Support 1: | 10.45 |
Support 2: | 5.93 |
52w High: | 31 |
52w Low: | 5.935 |
DarioHealth Corp. operates as a digital therapeutics company in the United States, Canada, the European Union, Australia, and New Zealand. The company offers Dario's metabolic solutions to address metabolic health needs, such as diabetes, hypertension, and weight management; Dario Musculoskeletal, which helps to prevent and treat the most common MSK conditions; Dario's behavioral health solution that optimizes access to evidence-based care; chronic condition management solutions; DarioEngage, a proprietary care management platform; and device-specific disposables test strip cartridges, lancets, and blood glucose monitoring systems. It also provides smart glucose meters; bluetooth connected blood pressure cuff; digital scales; biofeedback sensor devices; and diabetes management programs, including lifestyle changes, healthy eating, advanced tracking, and live coaching. The company was formerly known as LabStyle Innovations Corp. and changed its name to DarioHealth Corp. in July 2016. DarioHealth Corp. was incorporated in 2011 and is based in New York, New York.
EPS | -13.400 |
Book Value | 28.140 |
PEG Ratio | 0.00 |
Gross Profit | 3.315 |
Profit Margin (%) | -162.73 |
Operating Margin (%) | -171.35 |
Return on Assets (ttm) | -22.5 |
Return on Equity (ttm) | -66.9 |
Mon, 06 Oct 2025
$50B Annual Fall Costs — DarioHealth Integrates OneStep's Smartphone Clinical-Grade Fall Risk Assessment - Stock Titan
Mon, 06 Oct 2025
DarioHealth and OneStep Announce Strategic Collaboration to Integrate Smartphone-Only, Clinical-Grade Fall Risk Assessment Technology into Dario's Digital Health Multi-Condition Platform (2025-10-06) - Seeking Alpha
Thu, 25 Sep 2025
Digital Health Platform DarioHealth Explores Sale After Multiple Acquisition Offers, Raises $17.5M - Stock Titan
Thu, 25 Sep 2025
DarioHealth conducting strategic review after inbound interest (DRIO:NASDAQ) - Seeking Alpha
Mon, 22 Sep 2025
DarioHealth Announces $17.5 Million Private Placement of Common Stock Priced At-The-Market Under Nasdaq Rules - PR Newswire
Sun, 21 Sep 2025
DarioHealth Corp. (NASDAQ:DRIO) Stock's 42% Dive Might Signal An Opportunity But It Requires Some Scrutiny - simplywall.st
![]() StockChart iOS |
![]() StoxlineLite iOS |
![]() StoxlineLite iOS |
![]() OptionCalc iOS |
![]() StockChart Android |
![]() StoxlineLite Android |
![]() StoxlinePro Android |
![]() OptionCalc Android |